Aaron J. Kowalski, PhD
President and CEO
New York, NY
This activity is intended for the healthcare team caring for those living with type 1 diabetes, including diabetologists, adult and pediatric endocrinologists, primary care physicians, endocrinology advanced practice providers, pharmacists, nurses, dietitians, certified diabetes care and education specialists, and other healthcare professionals.
Statement of Need
Type 1 diabetes (T1D) is a challenging condition to manage for a number of physiologic and behavioral reasons. Regular exercise is important to help people with T1D improve health and well-being, achieve target lipid profiles, improve body composition, and reach personal goals related to fitness and glycemic control. Integrating physical activity into daily life is challenging for anyone, but those with T1D face additional barriers related to the management of blood glucose levels before, during, and after exercise, including a fear of hypoglycemia, which prevents many from starting exercise programs. People with T1D tend to be at least as inactive as the general population, with a large percentage of individuals not maintaining a healthy body mass and not achieving the minimum recommended weekly amount of moderate to vigorous aerobic activity. The American Diabetes Association Standards of Care recommend that people with diabetes receive care from a coordinated interdisciplinary team consisting of certified diabetes care and education specialists (CDCES), pharmacists, and primary care and specialty providers, including physicians, nurse practitioners, physician assistants, and nurses. The PEAK Program addresses the need for education among all members of the diabetes care team on safely and successfully planning for and managing different types of activity in individuals with T1D.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation..
This nursing activity has been approved for up to 0.5 contact hour.
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hour (0.05 CEU) of credit for pharmacists. ACPE #0476-0000-21-010-H01-P. This knowledge-based activity is designed for all pharmacists.
Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Instructions to Receive Credit
To receive credit, read the introductory CE material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 27, 2021
Expiration Date: October 25, 2023
Estimated Time to Complete This Activity: 30 minutes
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 24 months that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
Drug/Product Usage by Faculty
Off-label/unapproved drug uses or products are mentioned within this activity.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Ian Gallen, MD, CBE, has indicated no real or apparent conflicts.
Aaron J. Kowalski, PhD, has indicated no real or apparent conflicts.
Lori Laffel, MD, MPH
Consulting fees/advisory boards: Boehringer Ingelheim Pharmaceuticals, Inc., ConvaTec Group, Dexcom, Inc., Dompé, F. Hoffmann-La Roche Ltd., Insulet Corporation, Insulogic, Janssen Pharmaceuticals, Inc., Lilly, Medtronic, Inc., Novo Nordisk, Provention Bio
Contracted research: Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Lilly
Michael Riddell, PhD
Consulting fees/advisory boards: Indigo Diabetes, Insulet Corporation, Novo Nordisk, Supersapiens, Zealand Pharma, Zucara Therapeutics
Fees received for promotional/non-CE activities: Lilly, Insulet Corporation, Medtronic, Inc., Novo Nordisk, Sanofi-aventis U.S. Inc.
Ownership interest (stocks/stock options – excluding mutual funds): Supersapiens, Zucara Therapeutics
Becky Sulik, RD, LD, CDE
Consulting fees/advisory boards: Lilly
Other: Insulet Corporation, Medtronic, Inc., Tandem Diabetes Care, Inc.
Fees received for promotional/non-CE activities: Dexcom, Inc., Tandem Diabetes Care, Inc.
The peer reviewers and other activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email firstname.lastname@example.org.
Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available by clicking the "Continue" button below.
Click "Continue" to proceed through this activity and/or receive credit.
By clicking "Continue," you confirm that you have reviewed the CME information.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.